Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies
Jeong Soo Ahn, Sang Min Park, Chun Sick Eom, Sarah Kim, Seung-Kwon Myung
Korean J Fam Med. 2012;33(5):272-279.   Published online 2012 Sep 27     DOI: https://doi.org/10.4082/kjfm.2012.33.5.272
Citations to this article as recorded by Crossref logo
A dual role of proton pump inhibition on cancer: a critical review
Deniz Tuna Edizer, Zeynep Akcali, Asım Leblebici, Sıla Övgü Korkut, Ender Ellidokuz
Turkish Journal of Biochemistry.2023; 48(2): 135.     CrossRef
Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis
Huizhu Guo, Ruiqiu Zhang, Pei Zhang, Zhaoyang Chen, Yuqing Hua, Xin Huang, Xiao Li
Frontiers in Pharmacology.2023;[Epub]     CrossRef
The Effect of Proton Pump Inhibitor Use on Survival of Patients With Colorectal Cancer: A Study of a Racially Diverse Population
Adham E Obeidat, Gabriel Monti, Horyun Choi, Jared Acoba
Cureus.2023;[Epub]     CrossRef
Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data
Mi Jung Kwon, Kyeong Min Han, Joo-Hee Kim, Ji Hee Kim, Min-Jeong Kim, Nan Young Kim, Hyo Geun Choi, Ho Suk Kang
Cancers.2023; 15(23): 5606.     CrossRef
Proton pump inhibitors affect capecitabine efficacy in patients with stage II–III colorectal cancer: a multicenter retrospective study
Yoshiko Kitazume, Hitoshi Kawazoe, Ryuji Uozumi, Tomoe Yoshizawa, Hirotoshi Iihara, Hironori Fujii, Masaya Takahashi, Takahiro Arai, Yasushi Murachi, Yumiko Sato, Takahiro Mikami, Koji Hashiguchi, Tomoko Yamazaki, Katsuyuki Takahashi, Yukiyoshi Fujita, Yu
Scientific Reports.2022;[Epub]     CrossRef
The frequency of gastrointestinal parasitosis and the effect of proton pump inhibitor use on gastrointestinal parasitosis and histopathological findings in patients with dyspepsia
Elvina ALMURADOVA, Elvan ERDOGAN, Rashad ISMAYİLOV, Sebnem OKTEM USTUN, Rukiye VARDAR
Ege Tıp Dergisi.2022; 61(3): 397.     CrossRef
Proton Pump Inhibitors and Cancer Risk
Man-Li Zhang, Yu-Xin Fan, Rui Meng, Wen-Ke Cai, Sun-Jun Yin, Tao Zhou, Yan-Hua Huang, Ping Wang, Fang-Fang Jiang, Mei Yang, Gong-Hao He
American Journal of Clinical Oncology.2022; 45(11): 475.     CrossRef
Association between the chronic use of gastric acid suppressants and high‐risk colorectal polyps
Yasutoshi Shiratori, Takashi Ikeya, Naoki Ishii, Kazuki Yamamoto, Tetsuro Honda, Kenkei Hasatani, Naohiro Yoshida, Tsutomu Nishida, Tetsuya Sumiyoshi, Shu Kiyotoki, Masahiro Arai, Ryota Niikura
JGH Open.2021; 5(3): 371.     CrossRef
Helicobacter pylori and colorectal neoplasms: a concise review
Luiz Gonzaga Vaz COELHO, Maria Clara Freitas COELHO
Arquivos de Gastroenterologia.2021; 58(1): 114.     CrossRef
Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat
Venkateshwar Madka, Gaurav Kumar, Gopal Pathuri, Janani Panneerselvam, Yuting Zhang, Vishal Ganta, Stanley Lightfoot, Ronald Lubet, Chen S. Suen, Vernon E. Steele, Naveena B. Janakiram, Altaf Mohammed, Chinthalapally V. Rao
Cancer Prevention Research.2021; 14(11): 1009.     CrossRef
Proton pump inhibitors and colorectal cancer: A systematic review
Agastya Patel, Piotr Spychalski, Magdalena Antoszewska, Jaroslaw Regula, Jarek Kobiela
World Journal of Gastroenterology.2021; 27(44): 7716.     CrossRef
Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand
Journal of Gastroenterology.2020; 55(4): 453.     CrossRef
Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis
Nasser Alkhushaym, Abdulaali R. Almutairi, Abdulhamid Althagafi, Saad B. Fallatah, Mok Oh, Jennifer R. Martin, Hani M. Babiker, Ali McBride, Ivo Abraham
Expert Opinion on Drug Safety.2020; 19(3): 327.     CrossRef
Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population
Jeffrey K. Lee, Sophie A. Merchant, Jennifer L. Schneider, Christopher D. Jensen, Bruce H. Fireman, Charles P. Quesenberry, Douglas A. Corley
American Journal of Gastroenterology.2020; 115(5): 706.     CrossRef
Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies
Tianyi Ma, Meng Wu, Shengnan Jia, Lanlan Yang
International Journal of Colorectal Disease.2020; 35(12): 2157.     CrossRef
Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies
Hee-Eun Hong, A-Sol Kim, Mi-Rae Kim, Hae-Jin Ko, Min Kyu Jung
Cancers.2020; 12(8): 2220.     CrossRef
Proton pump inhibitors and colorectal cancer: more reassuring news
Her Hsin Tsai
GastroHep.2020; 2(4): 144.     CrossRef
Proton Pump Inhibitors
Stuart Jon Spechler
Medical Clinics of North America.2019; 103(1): 1.     CrossRef
Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer
Grace G. Wong, Vincent Ha, Michael P. Chu, Deonne Dersch-Mills, Sunita Ghosh, Carole R. Chambers, Michael B. Sawyer
Clinical Colorectal Cancer.2019; 18(1): 72.     CrossRef
Lifestyle and dietary environmental factors in colorectal cancer susceptibility
Neil Murphy, Victor Moreno, David J. Hughes, Ludmila Vodicka, Pavel Vodicka, Elom K. Aglago, Marc J. Gunter, Mazda Jenab
Molecular Aspects of Medicine.2019; 69: 2.     CrossRef
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito, Robert T. Jensen
International Journal of Molecular Sciences.2019; 20(20): 5128.     CrossRef
PPI use and oesophageal cancer: What if the results are true?
Nele Brusselaers, Lars Engstrand, Jesper Lagergren
Cancer Epidemiology.2018; 54: 139.     CrossRef
Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
In Cheol Hwang, Jooyoung Chang, Sang Min Park, Eric J. Duell
PLOS ONE.2018; 13(9): e0203918.     CrossRef
Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
In Cheol Hwang, Jooyoung Chang, Sang Min Park, Suminori Akiba
PLOS ONE.2017; 12(12): e0189114.     CrossRef
The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
Helen F. Boardman, Gordon Heeley
International Journal of Clinical Pharmacy.2015; 37(5): 709.     CrossRef
Risque moyen ou élevé de cancer colorectal : comment classer en 2014 ? Faut-il changer le paradigme ?
D. Heresbach, P. Pienkowski
Acta Endoscopica.2014; 44(5): 268.     CrossRef
Risque de néoplasie colorectale, comorbidités et facteurs environnementaux. Faut-il revoir les recommandations de dépistage en 2014 ?
D. Heresbach, P. Bulois
Acta Endoscopica.2014; 44(5): 240.     CrossRef
Comments on Statistical Issues in November 2012
Yong Gyu Park
Korean Journal of Family Medicine.2012; 33(6): 410.     CrossRef